Investor Relations

Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area of oncology with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has promising product candidates in clinical and late preclinical development and has entered into strategic collaborations with leading global pharmaceutical companies.

Recent News > MORE
Date Title  
Thursday, August 4, 2016 Five Prime Announces Second Quarter 2016 Results and Provides Business Update
Monday, July 18, 2016 Five Prime Therapeutics to Announce Second Quarter 2016 Financial Results and Host Conference Call on August 4
Upcoming and Recent Events > MORE
Date Title  
Thursday, August 4, 2016
4:30 PM ET
Five Prime Therapeutics, Inc. 2016 Q2 Quarterly Earnings Call
Supporting Materials
PDF Corporate Overview 901.6 KB   Add to Briefcase
Wednesday, June 8, 2016
2:30 PM ET
Jefferies 2016 Healthcare Conference
Supporting Materials
PDF View Presentation  2.7 MB   Add to Briefcase
Thursday, May 12, 2016
10:00 AM PT
Bank of America Merrill Lynch 2016 Health Care Conference
Supporting Materials
PDF View Presentation  9.3 MB   Add to Briefcase

FPRX (Common Stock)

Change (%)

Data as of 4:00 PM ET on Friday, August 26, 2016
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.